PURCHASE CONTRACT AGREEMENT Dated as of January 27, 2020 between ELANCO ANIMAL HEALTH INCORPORATED and DEUTSCHE BANK TRUST COMPANY AMERICAS, as Purchase Contract Agent, as Attorney-in-Fact for the Holders of Equity-Linked Securities from time to time...Purchase Contract Agreement • January 27th, 2020 • Elanco Animal Health Inc • Pharmaceutical preparations • New York
Underwriting AgreementUnderwriting Agreement • January 27th, 2020 • Elanco Animal Health Inc • Pharmaceutical preparations • New York
Elanco Animal Health Incorporated, an Indiana corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 22,694,732 shares (the “Firm Shares”) and, at the election of the Underwriters, up to 2,269,473 additional shares (the “Optional Shares”) of common stock, no par value (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
ELANCO ANIMAL HEALTH INCORPORATED, as Issuer, AND DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee Second Supplemental Indenture Dated as of January 27, 2020 to Indenture Dated as of August 28, 2018Second Supplemental Indenture • January 27th, 2020 • Elanco Animal Health Inc • Pharmaceutical preparations • New York
Underwriting AgreementUnderwriting Agreement • January 27th, 2020 • Elanco Animal Health Inc • Pharmaceutical preparations • New York
Elanco Animal Health Incorporated, an Indiana corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 11,000,000 5.00% tangible equity units (the “Units”) of the Company (said Units being hereinafter called the “Securities” and the offer and sale of the Securities hereunder being called the “Units Offering”).
